Proposed section structure
This topic is best organized around the unmet clinical need for early detection of beta cell failure, the biomarker discovery strategy, the statistical modeling approach, the clinical meaning of the three-miRNA signature, and the translational barriers that remain before implementation. The article therefore follows this structure: highlights, clinical background, study design and methods, key findings, mechanistic and clinical interpretation, limitations and generalizability, and conclusion with implementation considerations.
